A detailed history of Trellus Management Company, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Trellus Management Company, LLC holds 220,000 shares of CDXS stock, worth $653,400. This represents 0.59% of its overall portfolio holdings.

Number of Shares
220,000
Previous 251,460 12.51%
Holding current value
$653,400
Previous $704,000 41.05%
% of portfolio
0.59%
Previous 0.89%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023

SELL
$1.5 - $3.75 $47,190 - $117,975
-31,460 Reduced 12.51%
220,000 $415,000
Q2 2023

Jul 14, 2023

BUY
$2.21 - $4.43 $555,726 - $1.11 Million
251,460 New
251,460 $704,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $195M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Trellus Management Company, LLC Portfolio

Follow Trellus Management Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellus Management Company, LLC with notifications on news.